News search
Research 19 Apr 2024 The results, published in JACC, suggest that these factors could be used to predict the risk of developing dilated cardiomyopathy and adapt strategies for patient care and disease detection in genetic carriers of the disease |
Research 23 Jan 2024 The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis |
About the CNIC 29 Nov 2023 CNIC and the i+12 Institute co-lead one of the working groups of this initiative. |
Research 20 Nov 2023 Atherosclerosis, previously believed to be an irreversible progressive disease, can be reversed if risk factors are contolled early enough |
About the CNIC 31 Oct 2023 Dr Sancho heads the CNIC Immunobiology Laboratory, whose work focuses on research into the function of dendritic cells and macrophages, as key immune cells that modulate immunity and inflammation, and the use of these cells in immunotherapy in a wide range of diseases |
Research 23 Oct 2023 This disease, which can trigger sudden death in elite athletes, is caused by genetic mutations that affect proteins responsible for connecting and coordinating the muscle cells (myocytes) in the myocardium the heart’s muscular wall |
Research 29 May 2023 The new study, published in Nature Cardiovascular Research, will help to select the most effective and safe way to modulate angiogenesis in ischemic tissues or in cancer |
Research 3 Feb 2023 The discovery, published in the journal Immunity, identifies a new therapeutic route for conditions associated with obesity and metabolic syndrome, including cardiovascular disease |
Research 16 Jan 2023 Nature Cardiovascular Research: The 'guardian of the genome' protects against cardiovascular disease A CNIC study extends the understanding of how acquired mutations in blood cells act as a new cardiovascular risk factor |
- 1 of 7
- next ›